Sugi Predict

Sugi Predict / Compounds / SCHEMBL4457563

SCHEMBL4457563

SCHEMBL4457563

CC(C)OC(=O)c1ccc(N(C)C)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 3/20 0.63
▸ CA1 P00915 3/20 0.63
▸ CA2 P00918 3/20 0.63
▸ CA7 P43166 3/20 0.63
▸ CA9 Q16790 3/20 0.63
▸ CA14 Q9ULX7 3/20 0.63
▸ PDCD1 Q15116 1/20 0.58
▸ CD274 Q9NZQ7 1/20 0.58
▸ ALDH1A1 P00352 8/20 0.55
▸ HPGD P15428 6/20 0.55
▸ MAPT P10636 4/20 0.55
▸ CYP4F2 P78329 1/20 0.54
▸ CYP4A11 Q02928 1/20 0.54
▸ RAB9A P51151 5/20 0.50
▸ NPC1 O15118 4/20 0.50
▸ LMNA P02545 3/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ HSD17B10 Q99714 3/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ HTT P42858 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL701832 0.85 CA12 (0.83) CA12CA1CA2CA7CA9
SCHEMBL27402255 0.85 ALDH1A1 (0.52) CA12CA1CA2CA7CA9
SCHEMBL27667912 0.83 CA12 (0.79) CA12CA1CA2CA7CA9
SCHEMBL27955902 0.83 CA12 (0.79) CA12CA1CA2CA7CA9
SCHEMBL27667925 0.83 CA12 (0.79) CA12CA1CA2CA7CA9
SCHEMBL27668240 0.83 CA12 (0.79) CA12CA1CA2CA7CA9
SCHEMBL28761675 0.83 CA12 (0.79) CA12CA1CA2CA7CA9
SCHEMBL27667911 0.83 CA12 (0.79) CA12CA1CA2CA7CA9
SCHEMBL27647565 0.83 CA12 (0.79) CA12CA1CA2CA7CA9
SCHEMBL27667932 0.83 CA12 (0.79) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112126373-A Enhanced viscous functional base material and preparation method thereof 浙江长宇新材料有限公司 2020-12-25 — — CN claimed
EP-2913052-A1 Phototherapy compositions and methods OMJ Ireland Limited (PR) 2015-09-02 — — EP claimed
CN-112126373-B Enhanced viscous functional base material and preparation method thereof 浙江长宇新材料股份有限公司 2022-11-22 — — CN disclosed
CN-112126373-A Enhanced viscous functional base material and preparation method thereof 浙江长宇新材料有限公司 2020-12-25 — — CN disclosed
CN-112005140-A Partially light-emitting element, and partially light-emitting film, interlayer laminate, functional glass, and head-up display using the partially light-emitting element 日本化药株式会社 2020-11-27 — — CN disclosed
CN-109415605-A Self-healing surface protective film with acrylate functional topcoat 德莎欧洲股份公司 2019-03-01 — — CN disclosed
US-10189930-B2 Polymeric photoinitiators ALLNEX BELGIUM S.A. (BE) 2019-01-29 — — US disclosed
US-10000446-B2 Amino photo-reactive binder ALLNEX BELGIUM S.A. (BE) 2018-06-19 — — US disclosed
CN-105085470-A Stable isotopic labeled 2-isopropylthioxanthone and synthetic method thereof SHANGHAI RES INST CHEMICAL IND 2015-11-25 — — CN disclosed
US-9023889-B2 Use of ascorbic acid derivatives for the functionalization of matrices MERCK PATENT GMBH (DE) 2015-05-05 — — US disclosed
US-20100167936-A1 USE OF ASCORBIC ACID DERIVATIVES FOR THE FUNCTIONALIZATION OF MATRICES MERCK PATENT GESELLSCHAFT (DE) 2010-07-01 — — US disclosed
EP-0704764-B1 Photopolymerizable composition and photosensitive lithographic printing plate MITSUBISHI CHEM CORP (JP) 1998-03-25 — — EP disclosed
EP-0704764-A1 Photopolymerizable composition and photosensitive lithographic printing plate MITSUBISHI CHEMICAL CORPORATION (JP) 1996-04-03 — — EP disclosed
US-5498641-A PHOTOPOLYMERIZATION MITSUBISHI CHEMICAL CORPORATION (JP) 1996-03-12 — — US disclosed
EP-0619520-B1 Photopolymerizable composition MITSUBISHI CHEM CORP (JP) 1996-01-31 — — EP disclosed
EP-0619520-A1 Photopolymerizable composition Mitsubishi Chemical Corporation (JP) 1994-10-12 — — EP disclosed
US-5264513-A Dental adhesive KABUSHIKI KAISHA SHOFU (JP) 1993-11-23 — — US disclosed
EP-0206030-B1 PHOTOCURABLE COMPOSITION SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1992-01-02 — — EP disclosed
US-4756994-A Ethylenically unsaturated monomer, photopolymerizable monomer, polymerization inhibitor, nitrogen-containing compound SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1988-07-12 — — US disclosed
EP-0206030-A2 Photocurable composition SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1986-12-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10000446-B2 Amino photo-reactive binder ADGRE5, GP6, CD79B CA12 4135/4885CA1 4153/4885CA2 3760/4885
US-20100167936-A1 USE OF ASCORBIC ACID DERIVATIVES FOR THE FUNCTIONALIZATION OF MATRICES PROC, TTPA, COX6C CA12 314/4885CA1 787/4885CA2 1120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.